Genmab A GNMSF
NASDAQ GNMSF
$335.00 +15.00 (+4.69%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genmab A/S (GNMSF) Tax Provisions (2024 - 2026)

Genmab A's (GNMSF) quarterly Tax Provisions came in at $136.0 million in Q2 2025, down 15.53% YoY from $161.0 million in Q2 2024, and down 15.53% on a QoQ basis from $161.0 million in Q2 2024.

Genmab A/S (GNMSF) Tax Provisions (2024 - 2026) Analysis & Trends

Genmab A (GNMSF) has 2 years of Tax Provisions data on file, last reported at $136.0 million in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.00 Mn
Mar 31, 2026 -1.00 Mn
Jun 30, 2025 136.00 Mn
Jun 30, 2024 161.00 Mn